Physician profile
Fredrick J Jackson
NPI 1609807015
$4,100.22
in general payments reported to CMS, 2019-2025
17 companies · $856 in 2025
The $856 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $295 · 2021: $672 · 2022: $663 · 2023: $673 · 2024: $675 · 2025: $856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,204.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,877.21 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Bausch & Lomb Americas INC. | $483.44 | 2023-2025 | Vyzulta, Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $391.37 | 2020-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $180.05 | 2019-2023 | |
| Oyster Point Pharma, INC. | $177.83 | 2022-2024 | Tyrvaya |
| Allergan, INC. | $172.11 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $167.43 | 2019-2025 | Acuvue |
| Abbvie INC. | $114.36 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $109.15 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $91.51 | 2020-2021 | |
| Coopervision INC. | $79.83 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $57.44 | 2022 | |
| Dompe US, INC. | $56.20 | 2022-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $55.95 | 2019-2020 | |
| Harrow Eye, LLC | $37.83 | 2025 | Vevye |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $24.77 | 2023 | Tearcare System |
| Shire North American Group INC | $23.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fredrick Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.